Israel Discount Bank of New York’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-200
Closed -$38K 95
2019
Q1
$38K Hold
200
0.03% 255
2018
Q4
$39K Hold
200
0.03% 236
2018
Q3
$41K Hold
200
0.03% 245
2018
Q2
$37K Hold
200
0.02% 327
2018
Q1
$34K Hold
200
0.02% 336
2017
Q4
$35K Hold
200
0.02% 339
2017
Q3
$37K Hold
200
0.03% 321
2017
Q2
$34K Hold
200
0.03% 327
2017
Q1
$33K Sell
200
-1,530
-88% -$254K 0.03% 319
2016
Q4
$253K Buy
+1,730
New +$260K 0.23% 77

Other funds holding AMGN

Israel Discount Bank of New York's AMGN Position: Q2 2019 in Review

Israel Discount Bank of New York sold out of Amgen (AMGN) in Q2 2019, closing a stake of 200 shares — an estimated $38K sold.

Israel Discount Bank of New York first reported a position in AMGN in Q4 2016 and held it in 10 quarters. The position peaked at $253K in Q4 2016. 1,865 funds tracked by Wall St. Rank hold AMGN as of Q2 2019.

  • Israel Discount Bank of New York reported no remaining Amgen position as of Q2 2019 after selling out during the quarter.
  • Israel Discount Bank of New York sold 200 Amgen shares in Q2 2019, an estimated $38K.
  • Israel Discount Bank of New York first reported a position in Amgen in Q4 2016 and held it in 10 quarters.
  • Israel Discount Bank of New York's Amgen position peaked at $253K in Q4 2016.
  • 1,865 funds tracked by Wall St. Rank held Amgen as of Q2 2019.

Based on Israel Discount Bank of New York's 13F filing for Q2 2019, filed 14 Aug 2019.